Does lamotrigine (Lamictal) cause hyponatremia?

Lamotrigine Can Cause Hyponatremia, Though It Is Uncommon

Yes, lamotrigine (Lamictal) can cause hyponatremia, but it occurs much less frequently than with other antiepileptic drugs like carbamazepine or oxcarbazepine. 1, 2

Evidence and Clinical Context

The FDA drug label for Lamictal does not list hyponatremia as a primary adverse effect in its warnings and precautions sections 1. However, multiple case reports and clinical reviews document lamotrigine-associated hyponatremia in real-world practice 3, 2, 4, 5, 6.

Incidence and Risk Profile

• Carbamazepine and oxcarbazepine are the most common antiepileptic drugs causing hyponatremia 2, 7, 8
• Lamotrigine-induced hyponatremia has been reported but remains relatively rare compared to these agents 2, 7
• Other antiepileptic drugs including eslicarbazepine, valproate, levetiracetam, and gabapentin have also been implicated 2

High-Risk Scenarios

The risk of lamotrigine-induced hyponatremia increases substantially in specific clinical contexts:

• Polypharmacy with other antidepressants or antiepileptics: Combined treatment with lamotrigine plus venlafaxine or other agents that affect sodium balance significantly increases risk 5
• Elderly patients: Age is a documented risk factor for antiepileptic drug-induced hyponatremia 2, 4
• Patients with pre-existing fluid/electrolyte disorders: Those with diabetes insipidus or other conditions affecting water balance 6

Clinical Presentation

A documented case demonstrated severe symptomatic hyponatremia with lamotrigine that was temporally associated with Takotsubo cardiomyopathy, with sequential improvement after drug cessation 3. In a geriatric bipolar depression trial, one patient developed hyponatremia requiring drug discontinuation 4.

Monitoring Recommendations

Check serum sodium at baseline and 2-4 weeks after initiating or increasing lamotrigine dose, particularly in:

• Elderly patients (≥60 years)
• Those on concurrent medications affecting sodium (SSRIs, SNRIs, diuretics, carbamazepine)
• Patients with baseline sodium <135 mmol/L
• Those with polydipsia or other fluid balance disorders

Symptoms to Monitor

• Acute hyponatremia (<48 hours): Delirium, seizures, altered mental status 8
• Chronic hyponatremia (>48 hours): Lethargy, dizziness, weakness, headache, nausea, confusion 8

Management Algorithm

If hyponatremia develops (sodium <135 mmol/L):

1. Assess severity and symptoms:

   • Severe (<120-125 mmol/L) or symptomatic: Consider hospitalization and acute treatment
   • Mild-moderate (125-134 mmol/L) and asymptomatic: Outpatient management possible

2. Exclude other causes:

   • Review all medications (diuretics, SSRIs, SNRIs)
   • Assess volume status
   • Check urine sodium and osmolality

3. Treatment options based on severity:

   • Symptomatic/severe: Discontinue lamotrigine immediately; consider 3% saline if severely symptomatic 9
   • Asymptomatic mild: Reduce lamotrigine dose or switch to alternative antiepileptic drug with lower hyponatremia risk (levetiracetam, gabapentin) 7
   • Conservative measures: Adequate salt/protein intake, fluid restriction 500 mL/day initially 9

Common Pitfall

Do not overlook hyponatremia in patients on lamotrigine plus antidepressants (particularly SNRIs like venlafaxine), as this combination substantially increases risk despite lamotrigine alone having relatively low risk 5. The syndrome of inappropriate antidiuretic hormone (SIADH) can result from this combination, potentially leading to serious cardiovascular complications including sudden death in epilepsy patients 5.